These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 25547792)

  • 1. Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium.
    Rondini S; Micoli F; Lanzilao L; Gavini M; Alfini R; Brandt C; Clare S; Mastroeni P; Saul A; MacLennan CA
    Infect Immun; 2015 Mar; 83(3):996-1007. PubMed ID: 25547792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease.
    Lanzilao L; Stefanetti G; Saul A; MacLennan CA; Micoli F; Rondini S
    PLoS One; 2015; 10(10):e0139847. PubMed ID: 26445460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of conjugation chemistry on the immunogenicity of S. Typhimurium conjugate vaccines.
    Stefanetti G; Rondini S; Lanzilao L; Saul A; MacLennan CA; Micoli F
    Vaccine; 2014 Oct; 32(46):6122-9. PubMed ID: 25192974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates.
    Simon R; Wang JY; Boyd MA; Tulapurkar ME; Ramachandran G; Tennant SM; Pasetti M; Galen JE; Levine MM
    PLoS One; 2013; 8(5):e64680. PubMed ID: 23741368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal
    Micoli F; Rondini S; Alfini R; Lanzilao L; Necchi F; Negrea A; Rossi O; Brandt C; Clare S; Mastroeni P; Rappuoli R; Saul A; MacLennan CA
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10428-10433. PubMed ID: 30262653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.
    Tennant SM; Schmidlein P; Simon R; Pasetti MF; Galen JE; Levine MM
    Infect Immun; 2015 Dec; 83(12):4504-12. PubMed ID: 26351285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium.
    Kong Q; Yang J; Liu Q; Alamuri P; Roland KL; Curtiss R
    Infect Immun; 2011 Oct; 79(10):4227-39. PubMed ID: 21768282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge.
    Huang C; Liu Q; Luo Y; Li P; Liu Q; Kong Q
    Vaccine; 2016 Aug; 34(36):4285-92. PubMed ID: 27423383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis.
    Simon R; Tennant SM; Wang JY; Schmidlein PJ; Lees A; Ernst RK; Pasetti MF; Galen JE; Levine MM
    Infect Immun; 2011 Oct; 79(10):4240-9. PubMed ID: 21807909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal Antibodies Elicited by Immunization With an O- Polysaccharide Glycoconjugate Vaccine Protect Infant Mice Against Lethal
    Baliban SM; Curtis B; Amin MN; Levine MM; Pasetti MF; Simon R
    Front Immunol; 2019; 10():2124. PubMed ID: 31555302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains.
    Tennant SM; Wang JY; Galen JE; Simon R; Pasetti MF; Gat O; Levine MM
    Infect Immun; 2011 Oct; 79(10):4175-85. PubMed ID: 21807911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sugar-Protein Connectivity Impacts on the Immunogenicity of Site-Selective Salmonella O-Antigen Glycoconjugate Vaccines.
    Stefanetti G; Hu QY; Usera A; Robinson Z; Allan M; Singh A; Imase H; Cobb J; Zhai H; Quinn D; Lei M; Saul A; Adamo R; MacLennan CA; Micoli F
    Angew Chem Int Ed Engl; 2015 Nov; 54(45):13198-203. PubMed ID: 26350581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive African Salmonella Typhimurium induces bactericidal antibodies against O-antigens.
    Rondini S; Lanzilao L; Necchi F; O'Shaughnessy CM; Micoli F; Saul A; MacLennan CA
    Microb Pathog; 2013 Oct; 63():19-23. PubMed ID: 23756206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and protective efficacy against
    Schuster O; Sears KT; Ramachandran G; Fuche FJ; Curtis B; Tennant SM; Simon R
    Hum Vaccin Immunother; 2019; 15(6):1436-1444. PubMed ID: 29873578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and efficacy following sequential parenterally-administered doses of Salmonella Enteritidis COPS:FliC glycoconjugates in infant and adult mice.
    Baliban SM; Curtis B; Toema D; Tennant SM; Levine MM; Pasetti MF; Simon R
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006522. PubMed ID: 29791435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Salmonella enterica serovar Typhimurium TTSS-2 deficient fur mutant as safe live-attenuated vaccine candidate for immunocompromised mice.
    Vishwakarma V; Pati NB; Chandel HS; Sahoo SS; Saha B; Suar M
    PLoS One; 2012; 7(12):e52043. PubMed ID: 23284865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation on Sugar-Protein Connectivity in Salmonella O-Antigen Glycoconjugate Vaccines.
    De Benedetto G; Salvini L; Gotta S; Cescutti P; Micoli F
    Bioconjug Chem; 2018 May; 29(5):1736-1747. PubMed ID: 29697244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa.
    Baliban SM; Yang M; Ramachandran G; Curtis B; Shridhar S; Laufer RS; Wang JY; Van Druff J; Higginson EE; Hegerle N; Varney KM; Galen JE; Tennant SM; Lees A; MacKerell AD; Levine MM; Simon R
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005493. PubMed ID: 28388624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accessibility of O Antigens Shared between
    Ahmed A; Akhade AS; Qadri A
    J Immunol; 2020 Jul; 205(2):438-446. PubMed ID: 32540995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.
    McKelvie ND; Khan SA; Karavolos MH; Bulmer DM; Lee JJ; DeMarco R; Maskell DJ; Zavala F; Hormaeche CE; Khan CM
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):237-46. PubMed ID: 18177343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.